David Weinstein
Research Subjects
David Weinstein has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Brandon DuBose Bushnell
Orthopaedics and Sports Medicine, Harbin Clinic, Rome, GA, USA
3 shared publications - Joshua Port
Department of Orthopaedic Surgery, University of Pittsburgh Medical School, Head Team Physician Altoona Curve AA Baseball, Altoona, PA, USA
3 shared publications - Melissa A. Wright
Department of Orthopedic Surgery, Washington University School of Medicine, St. Louis, MO, USA
3 shared publications Akin Cil
University of Missouri-Kansas City, Department of Orthopedic Surgery, Kansas City, MO, USA
2 shared publications- Claudius D. Jarrett
Wilmington Health Orthopaedics and Sports Medicine, 1202 Medical Center Dr., Wilmington, NC 28401, USA
2 shared publications - Mina Abdelshahed
Union County Orthopaedic Group, Linden, NJ, USA
2 shared publications
Latest Publications
- Open Access
- 10 April 2026
- Published by Elsevier in JSES Reviews, Reports, and Techniques
- Vol. 6 (3) , 100748
Augmentation for rotator cuff repair – clinical use patterns and limited patient access: the American Shoulder and Elbow Surgeons bio-advocacy work group survey
- 10 April 2026
- Published by Elsevier in JSES Reviews, Reports, and Techniques
- Vol. 6 (3) , 100748
Open AccessAugmentation for rotator cuff repair – clinical use patterns and limited patient access: the American Shoulder and Elbow Surgeons bio-advocacy work group survey
- 20 November 2023
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 33 (6) , e336-e342
The impact of prior authorization review on orthopaedic subspecialty care: a prospective multicenter analysis
- 20 November 2023
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 33 (6) , e336-e342
The impact of prior authorization review on orthopaedic subspecialty care: a prospective multicenter analysis
- 17 April 2019
- Published by Oxford University Press (OUP) in American Journal of Health-System Pharmacy
- Vol. 76 (9) , 574-580
Allergic reactions to small-molecule drugs: Will we move from reaction to prediction?
This primer provides background and an update on immune mechanisms which allow small-molecule drugs to trigger drug allergy. For many years, understanding of drug allergy was limited. The hapten model of drug allergy applies only to a subset of drugs known to cause allergic reactions. More recently, the understanding of immune reactions has expanded to include pharmacologic interactions with the molecules involved in immune identity and surveillance. These insights are presented and discussed here. Greater understanding of allergic reactions to drugs offers the promise to move from a position of reacting to immune reactions to a more proactive model. This may translate to new opportunities to characterize risk in drug development, confirm the nature of reactions in clinical settings, enhance the targeting of alerts, and ultimately to allow patient-specific prediction.
- 17 April 2019
- Published by Oxford University Press (OUP) in American Journal of Health-System Pharmacy
- Vol. 76 (9) , 574-580
Allergic reactions to small-molecule drugs: Will we move from reaction to prediction?
This primer provides background and an update on immune mechanisms which allow small-molecule drugs to trigger drug allergy. For many years, understanding of drug allergy was limited. The hapten model of drug allergy applies only to a subset of drugs known to cause allergic reactions. More recently, the understanding of immune reactions has expanded to include pharmacologic interactions with the molecules involved in immune identity and surveillance. These insights are presented and discussed here. Greater understanding of allergic reactions to drugs offers the promise to move from a position of reacting to immune reactions to a more proactive model. This may translate to new opportunities to characterize risk in drug development, confirm the nature of reactions in clinical settings, enhance the targeting of alerts, and ultimately to allow patient-specific prediction.